These findings underscore the significance of modulating PINK1/Parkin-dependent mitophagy as a therapeutic strategy in coronavirus-induced intestinal disease, highlighting quercetin's capacity to restore epithelial homeostasis by stabilizing mitochondrial function and limiting inflammation. The gene discussed is PRKN; the disease is intestinal disorder.